secwatch.observer — SEC 8-K summary
======================================

Issuer:     UTAH MEDICAL PRODUCTS INC (UTMD)
CIK:        0000706698
Form:       8-K
Filed at:   2023-04-25T23:59:59+00:00
Accession:  0001096906-23-000901
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01, 99.1
LLM model:  deepseek-v4-flash:cloud@v2

UTMD Q1 2023: NI +19.2% to $4.2M, EPS $1.16; OUS sales +23%; cash $80.9M
------------------------------------------------------------------------

- Consolidated sales $12.5M, up 1.6% YoY; OUS sales up 23% (28% constant currency), domestic down 10%.
- Operating income margin 35.5% (down from 36.7%) due to $348K higher litigation expenses.
- Net income $4.2M, EPS $1.16 vs $0.96; NI margin 33.7% vs 28.7%.
- Cash and investments $80.9M, up $5.9M from Dec 31, 2022; no debt.
- Management reaffirms FY2023 objectives; regular quarterly dividend $0.295/share paid in Q1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/706698/000109690623000901/0001096906-23-000901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/706698/000109690623000901/utmd-20230425.htm
  HTML page:      https://secwatch.observer/filing/0001096906-23-000901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer